Log In
Print
BCIQ
Print
Print this Print this
 

Erythrocyte Encapsulated Adenosine Deaminase (EE-ADA) (OT-81)

  Manage Alerts
Collapse Summary General Information
Company Orphan Technologies Ltd.
DescriptionEnzyme replacement therapy (ERT) comprised of adenosine deaminase encapsulated within autologous erythrocytes
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard Indication Metabolic (unspecified)
Indication DetailsTreat severe combined immunodeficiency (SCID) due to adenosine deaminase deficiency (ADA-SCID)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today